Stevens Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,594
Closed -$628K 352
2023
Q3
$628K Buy
+5,594
New +$710K 0.18% 131
2019
Q4
Sell
-16,378
Closed -$2.18M 816
2019
Q3
$2.18M Sell
16,378
-118,647
-88% -$15.3M 0.2% 136
2019
Q2
$15.4M Buy
+135,025
New +$15.8M 0.69% 30
2019
Q1
Sell
-82,150
Closed -$8.27M 920
2018
Q4
$8.27M Buy
+82,150
New +$9.24M 0.43% 58
2018
Q2
Sell
-154,195
Closed -$16.3M 1009
2018
Q1
$16.3M Buy
+154,195
New +$17.9M 0.62% 31
2017
Q2
Sell
-7,181
Closed -$851K 1114
2017
Q1
$851K Buy
+7,181
New +$814K 0.03% 454
2016
Q4
Sell
-5,810
Closed -$733K 1148
2016
Q3
$733K Buy
+5,810
New +$718K 0.03% 491
2016
Q2
Sell
-118,505
Closed -$12.3M 1159
2016
Q1
$12.3M Buy
+118,505
New +$11.5M 0.49% 44
2015
Q4
Sell
-25,998
Closed -$2.37M 1182
2015
Q3
$2.37M Sell
25,998
-98,584
-79% -$9.88M 0.11% 205
2015
Q2
$13.2M Buy
124,582
+74,920
+151% +$8.29M 0.48% 48
2015
Q1
$5.67M Sell
49,662
-44,362
-47% -$5.06M 0.2% 133
2014
Q4
$10.4M Buy
94,024
+71,284
+313% +$7.51M 0.35% 82
2014
Q3
$2.22M Sell
22,740
-117,390
-84% -$11.5M 0.07% 318
2014
Q2
$14.1M Sell
140,130
-34,785
-20% -$3.39M 0.38% 70
2014
Q1
$16.1M Buy
+174,915
New +$16.1M 0.43% 67
2013
Q3
Sell
-143,046
Closed -$10.4M 1240
2013
Q2
$10.4M Buy
+143,046
New +$10.7M 0.35% 83

Other funds holding ZBH

Stevens Capital Management's ZBH Position: Q4 2023 in Review

Stevens Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 5,594 shares — an estimated $628K sold.

Stevens Capital Management first reported a position in ZBH in Q2 2013 and held it in 16 quarters. The position peaked at $16.3M in Q1 2018. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

  • Stevens Capital Management reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
  • Stevens Capital Management sold 5,594 Zimmer Biomet shares in Q4 2023, an estimated $628K.
  • Stevens Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 16 quarters.
  • Stevens Capital Management's Zimmer Biomet position peaked at $16.3M in Q1 2018.
  • 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Stevens Capital Management's 13F filing for Q4 2023, filed 2 Feb 2024.